ClinicalTrials.gov
ClinicalTrials.gov Menu

DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (TARGET-I)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02197169
Recruitment Status : Completed
First Posted : July 22, 2014
Last Update Posted : July 16, 2018
Sponsor:
Information provided by (Responsible Party):
DNAtrix, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 15, 2018
  Actual Study Completion Date : March 15, 2018